Page last updated: 2024-11-02

palmidrol and Peripheral Nerve Diseases

palmidrol has been researched along with Peripheral Nerve Diseases in 3 studies

palmidrol: a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection
palmitoyl ethanolamide : An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.

Research Excerpts

ExcerptRelevanceReference
"Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of several chemotherapeutic agents, such as Paclitaxel."1.72Palmitoylethanolamide Mitigates Paclitaxel Toxicity in Primary Dorsal Root Ganglion Neurons. ( Dehghani, F; Elfarnawany, A, 2022)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Elfarnawany, A1
Dehghani, F1
Parisi, S1
Ditto, MC1
Borrelli, R1
Fusaro, E1
Di Cesare Mannelli, L1
D'Agostino, G1
Pacini, A1
Russo, R1
Zanardelli, M1
Ghelardini, C1
Calignano, A1

Other Studies

3 other studies available for palmidrol and Peripheral Nerve Diseases

ArticleYear
Palmitoylethanolamide Mitigates Paclitaxel Toxicity in Primary Dorsal Root Ganglion Neurons.
    Biomolecules, 2022, 12-14, Volume: 12, Issue:12

    Topics: Animals; Antineoplastic Agents, Phytogenic; Ganglia, Spinal; Paclitaxel; Peripheral Nervous System D

2022
Efficacy of a fixed combination of palmitoylethanolamide and acetyl-l-carnitine (PEA+ALC FC) in the treatment of neuropathies secondary to rheumatic diseases.
    Minerva medica, 2021, Volume: 112, Issue:4

    Topics: Acetylcarnitine; Aged; Amides; Analgesics, Non-Narcotic; Carpal Tunnel Syndrome; Drug Administration

2021
Palmitoylethanolamide is a disease-modifying agent in peripheral neuropathy: pain relief and neuroprotection share a PPAR-alpha-mediated mechanism.
    Mediators of inflammation, 2013, Volume: 2013

    Topics: Amides; Animals; Blotting, Western; Endocannabinoids; Ethanolamines; Hyperalgesia; Immunohistochemis

2013